1,041
Participants
Start Date
September 30, 1991
Primary Completion Date
October 31, 1999
Study Completion Date
March 31, 2012
Placebo
Two 100 Og puffs budesonide placebo bid + two 90 Og puffs albuterol prn OR four 2 mg puffs nedocromil placebo bid + two 90 Og puffs albuterol prn.
Nedocromil
Four 2 mg puffs bid + two 90 Og puffs albuterol prn
Budesonide
Two 100 Og puffs bid + two 90 Og puffs albuterol prn.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
CAMP Steering Committee
UNKNOWN
Johns Hopkins Bloomberg School of Public Health
OTHER